Home/Vicinitas Therapeutics/Raphael Rousseau, M.D., Ph.D.

RR

Raphael Rousseau, M.D., Ph.D.

Interim CEO

Vicinitas Therapeutics

Therapeutic Areas

Oncology Rare Disease

Leadership Team at Vicinitas Therapeutics

Daniel Nomura, Ph.D.

Scientific Co-Founder

View full Vicinitas Therapeutics profile